Dr Julie Rayes was awarded a reputable Fellowship to study, test and repurpose drugs to limit thrombo-inflammation caused by infection or congenital disorders.
A new EU-funded collaborative research project will develop the first integrative digital platform for diagnosing atrial cardiomyopathy.
Experts have come together to discuss the latest innovations in atrial fibrillation research and publish a set of agreed clinical and research recommendations.
Article about Professor Dipak Kotecha, Associate Editor of Karger and Professor of Cardiology at the Institute of Cardiovascular Sciences, where he talks about himself and his research.
A clinical trial has shown that digoxin has the same effect on physical wellbeing as beta-blockers when treating patients with permanent atrial fibrillation.
Dr Christopher O'Shea from at the Institute of Cardiovascular Sciences has been awarded a prestigious Postdoctoral Fellowship from the Wellcome Trust.
Mr Nigel Drury, Clinician Scientist in Paediatric Cardiac Surgery at the University of Birmingham, has received the prestigious Hunterian Professorship.
Dr James Guggenheim has been appointed as a Birmingham Fellow with the Institute of Cardiovascular Sciences at the University of Birmingham.
Funded by the National Institute for Health Research (NIHR) and the Department of Health & Social Care, DaRe2THINK will develop an entirely new way to run large clinical trials for patient benefit in the NHS.
A recently published study by scientists from King's College London, University of Oxford, University of Glasgow and University of Birmingham sheds light on the mechanism of action of an exciting new class of drugs.